A field analysis for revenue cycle management companies — and the operators who run them — navigating the structural reset of 2026.
Healthcare's operating margins have stabilized at historically thin levels. The labor expense that funds the revenue cycle has structurally repriced upward. The result is a financial environment where the cost of getting paid has become the constraint on getting paid at all.
U.S. healthcare provider organizations entered 2026 with median operating margins of 1.3% (Kaufman Hall, year-end 2025; early 2026 readings have run below that level). The labor cost that funds the revenue cycle has structurally repriced upward — clinical and administrative staff compensation up 12% to 38% across role categories over the past five years (MGMA, 2025). And the industry has spent two decades automating administrative transactions, only to leave an estimated $21 billion on the floor each year in unrealized savings (CAQH 2025 Index, released February 2026) — most of it concentrated in the manual residue between transactions that look electronic on paper.
This report sizes the gap, names the doctrine — Margin Recovery — and outlines the five questions every RCM leader should bring to their 2026 strategy review. The data is industry-wide. The conclusions are operationally specific.
The traditional growth-out-of-compression playbook does not pencil out at 1.3% operating margins with structurally repriced labor. Capital deployed at the revenue-cycle layer compounds harder than capital deployed at the volume layer.
Headcount-as-a-percent-of-collections must replace simple headcount as the operational metric reported to the board. The linear coupling between claim volume and FTE count is the equation that must break, and 2026 budget cycles are the planning horizon where that decision lands.
The fragmented vendor stack between charge capture and cash deposit now carries integration and reconciliation costs that often exceed subscription costs. Consolidation onto a unified system of record becomes a margin lever, not a procurement preference.
What 2026 looks like from the CFO's chair — and why "tight margin" has become a structural feature rather than a recoverable disruption.
Health systems entered 2026 with a financial profile that, by historical standards, would have been a warning. By the standards of the last five years, it counts as stable.
Kaufman Hall, drawing from monthly operating data across more than 1,300 hospitals, reported a year-to-date adjusted operating margin of 1.3% through December 2025. The most recent monthly read — March 2026 data published May 18, 2026 — showed margins improving month-over-month but still running below 2025 levels. The headline "stable" frame masks a continuing compression underneath: 2026 is not recovering from the structural reset; it is settling into it.
These are not numbers that fund growth, capital reinvestment, or sustained workforce competition. They are numbers that fund continuity.
Beneath the headline margin, three structural shifts are reshaping how healthcare gets funded.
Labor now accounts for 84.4% of total expense in physician practices (Kaufman Hall, Q4 2025). The 2025 MGMA Compensation Data Report — drawn from over 4,300 medical groups — documented median total compensation increases of 12% to 38.4% across clinical and support role categories over five years. The pattern is not cyclical wage pressure that softens with the labor market. It is a structural reset that holds.
The implication for the revenue cycle is direct: every additional FTE added to handle volume growth is added at a higher unit cost than the previous one. The math of "scale absorbs cost" no longer applies the way it did a decade ago.
The share of revenue coming from government payers and uninsured patients continues to climb. Kaufman Hall flagged the persistent gap between gross and net operating revenue (December 2025: 11% YoY growth in gross revenue versus 8% in net) as the visible signature of payer mix erosion. The same dollar of charges produces fewer dollars of net collections this year than it did last year — and the gap is widening, not narrowing.
The third shift is less visible in margin data but more consequential operationally: the pace at which payers introduce new claim rules, medical necessity criteria, and prior authorization requirements has accelerated. Medicare Advantage prior authorization volume rose to 53 million requests in 2024 (from 49.8 million in 2023, per KFF analysis of CMS data), and the partial-or-full denial rate on those requests climbed from 6.4% to 7.7% in a single year. The CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) entered its operational phase in January 2026; the first public prior authorization performance metric reports were due March 31, 2026; the FHIR API compliance deadline lands January 1, 2027. The regulatory clock is already running.
The compounding effect of these three shifts — repricing labor, eroding payer mix, accelerating rule complexity — is what makes the 1.3% operating margin a structural condition rather than a recoverable cycle.
The "growth out of compression" playbook — adding volume to dilute fixed costs — does not work when the costs are no longer fixed. The "outsource the burden" playbook — shifting RCM work to third-party services priced as a percentage of collections — does not work when the cost-to-collect ratio is itself the constraint. The remaining playbook is operational: reduce the labor required to collect each dollar without giving up the dollar.
Industry benchmarks for cost-to-collect haven't materially changed in a decade. The operating margin those numbers sit on has.
Industry benchmarks for cost-to-collect in healthcare have remained directionally stable for years: 2% to 4% of net patient revenue for high-performing operations, with the cohort average drifting closer to 5% over the past five years (MGMA practice operations data; MD Clarity benchmark analysis).
What changed is the operating margin those numbers sit on.
The math is unforgiving. A 1.3% operating margin against a 5% cost-to-collect ratio means revenue cycle operations consume nearly four times the profit they enable. Push cost-to-collect to 6% — a not-uncommon trajectory under FTE growth pressure — and the operation is funding cycle costs out of capital reserves.
FTE growth in response to claim volume growth. Claim volumes have risen across most service categories alongside outpatient migration. Most RCM operations and provider practices have responded by adding billers, A/R specialists, and denial coordinators. Each one is added at a labor cost that is structurally higher than the FTE they replaced (see Section 4).
The widening manual residue between increasingly automated transactions. Eligibility verification, claim status inquiry, remittance posting, and prior authorization have all seen rising electronic-adoption rates. But the workflows that wrap those transactions — portal follow-up, IVR navigation, exception triage, payer-specific routing — have remained labor-bound. Section 5 sizes this residue.
Denial rates have climbed every year for a decade. The economic weight of denials now extends well past the face value of denied claims.
The denial trajectory is the clearest single signal of payer rule velocity outpacing provider operational response. Experian Health's 3rd Annual State of Claims Survey (September 2025) found that 41% of providers now report initial claim denial rates of 10% or higher, up from 38% in 2024 and 30% in 2022 — the rate has climbed every year the survey has been run. Aptarro's 2025 analysis of more than 441 million claim remits put the average initial denial rate at 11.81% in 2024, up from approximately 10.2% several years earlier.
Underneath the volume, the composition has shifted: a growing share of denials now originate from Medicare Advantage and large commercial plans where authorization, medical necessity, and coding-specificity requirements have ratcheted upward. Experian's survey found 70% of providers say submitting clean claims is now more difficult than it was in 2024 — and 50% identified missing or inaccurate claim data as the number one driver of rising denial rates.
The economic weight of denials extends well past the face value of denied claims. Industry analyses size cross-payer friction — denied revenue plus the rework cost of recovery — at 3% to 5% of net patient revenue.
A $500M net-revenue operation at the midpoint of that 3%–5% range carries $20M annually in either lost or rework-consumed revenue from denial friction. At the high end, $25M. For comparison, the same operation's operating margin at the Kaufman Hall 1.3% median would be approximately $6.5M. The denial loss is several multiples of the operating profit it sits inside.
Volume growth at the prior-authorization layer is one of the most visible signals of escalating payer complexity. Medicare Advantage insurers alone processed 53 million prior authorization requests in 2024, up from 49.8 million in 2023 (KFF analysis of CMS data, published January 2026). In the same window, the share of those requests denied in part or full climbed from 6.4% to 7.7% — more volume and a higher denial rate within the volume. Each authorization layer added to a service category becomes a denial vector for the providers serving that population. The downstream effect is a denial backlog that grows even when individual claim quality holds steady.
Denial management can no longer sit at the back of the cycle. Treating denials as exception work — clean up after submission — is what generates the FTE compounding problem in Section 4. Denial intelligence has to live in the same workflow surface as eligibility, coding, and submission, with the same automation depth. A claim caught and corrected before submission costs cents. The same claim worked through appeals after denial costs hundreds of dollars in labor.
When volume grows, FTEs grow alongside. When labor reprices, every FTE costs more. The compounding is mathematical, not theoretical.
The 2025 MGMA Stat poll of practice leaders is the cleanest reading available of where the cost pressure lives: 65% identified labor as the single largest area of cost increase, ahead of supplies (17%), technology (12%), and facilities (4%).
Under that headline, the labor data divides into three trends, each of which compounds the next.
The 2025 MGMA Compensation Report documented median total compensation increases of 12% to 38.4% across role categories over five years. 2025 budgeted increases ran 4.5% (front desk), 5.5% (medical assistants and nurse practitioners), and 5% (other clinical and APP roles). One-third of medical groups (35%) reported budgeting more than usual for 2025 — a pattern MGMA characterizes as "long-term recalibration," not short-term disruption.
MGMA's revenue analysis suggests that median practices may need 6% or more additional gross revenue just to maintain current margins — a moving target that more than half of medical groups missed in 2025. Only 56% of medical group leaders reported year-to-date revenue increases relative to the same period in 2024.
MGMA's 2025 staffing surveys identify revenue cycle workers, medical coders, contact center representatives, and front desk staff as the role categories where shortages are most persistent. The downstream effect is a structural cap on how fast an operation can hire its way through volume growth, even when the budget is approved.
Charges grow. FTEs grow alongside them, because routine claim work scales linearly with claim volume. The cost-per-FTE grows too, because labor is repricing structurally. Net effect: labor expense per claim is increasing, even before accounting for denial rework. The operating margin available to absorb that increase is 1.3%.
Two decades of administrative-transaction automation. $258 billion in costs avoided. $21 billion still on the floor. The unrealized opportunity isn't where most observers think.
After two decades of administrative-transaction automation effort across payers and providers, healthcare avoided an estimated $258 billion in administrative costs in 2024 (CAQH 2025 Index, released February 2026, drawing from data on 600+ provider organizations and health plans representing 63% of insured lives).
The work is not finished.
CAQH sized an additional $21 billion in annual savings still unrealized across the transaction set the Index tracks. The same Index documented an inflection point in AI adoption: more than 50% of health plans and 25% of provider organizations now use AI tools in administrative workflows. The asymmetry — payers ahead of providers — is itself an operational signal. The provider side of every administrative transaction is on the slower side of the AI adoption curve, which is also where the cost-to-collect erosion lives.
The unrealized opportunity does not concentrate where most observers expect — in the lowest-adoption transactions. It concentrates in the manual residue sitting between transactions that look mostly automated on paper.
By transaction, ordered by 2026 strategic priority:
The single most actionable transaction in 2026, because the federal timeline is set and the first milestone has already passed. The CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) entered its operational phase on January 1, 2026 — affected payers (Medicare Advantage, Medicaid, CHIP, and Qualified Health Plans on the FFE) now must issue PA decisions within 7 calendar days for standard requests and 72 hours for expedited requests, with specific denial reasons required. The first public prior authorization performance metric reports were due March 31, 2026. The FHIR-based Prior Authorization API compliance deadline lands January 1, 2027. CMS projects approximately $15 billion in federal savings over 10 years from the full rule. The unit economics already justify the investment — manual prior auth costs approximately $3.41 per transaction and takes 24 minutes; fully electronic costs $0.05 (CAQH 2024). The adoption gap (35% electronic) and the regulatory pressure converge into the largest single-transaction recovery opportunity on the calendar.
Eligibility looks like a solved problem at the adoption-rate level. CAQH's savings sizing reveals it isn't. The gap lives in workflows that combine electronic verification with manual portal follow-up, IVR escalation, or duplicate verification across systems. Every additional minute of staff time per eligibility check, multiplied across daily volume, is the residue.
Claim status is the transaction that drives A/R follow-up burden. The 20% non-electronic share is concentrated in payer portals and direct calls. Each one is a margin-erosion event in an environment where labor is 84% of expense. The most direct line between automation gap and FTE-hours saved.
Submission is the highest-adoption transaction in the Index. The economic opportunity has moved to the front-end quality of the submission — eligibility integrity, coding accuracy, modifier appropriateness, prior authorization where required. Clean claim rate becomes the operative metric. Section 3's denial economics live or die at this transaction.
ERA-based payment posting is widely available, but a meaningful portion of the workflow still requires manual reconciliation — line-item variance, contractual adjustments, secondary insurance routing. This is where automation tends to stop being "the system does it" and start being "the system flags, a person resolves." The MGMA-cited "5% of collections" cost-to-collect figure includes the manual posting time that lives in this gap.
Attachments are the most operationally sensitive transaction in the Index, because they depend on cross-system integration that breaks easily under pressure. The 2025 regression tells the structural story: automation is not linear. Incomplete workflows revert when operating teams get stretched. This is the strongest argument for treating automation as a continuous workflow discipline, not a one-time project.
This isn't a "do automation" pitch — most RCM operators already do some. The economic question is whether your operation has eliminated the manual residue across these transactions. The total unrealized opportunity, summed across the Index transaction set: ~$21 billion annually. That is the unclaimed portion of Margin Recovery — sitting on the table industry-wide.
Revenue Recovery is an established discipline focused on the top line. Margin Recovery is the equivalent posture for the bottom line — and the dominant strategic frame for 2026.
Revenue Recovery is an established discipline in revenue cycle operations. It points at the top line: claims you should have been paid for but weren't, recovered through appeals, secondary submissions, and patient collections. Every RCM operator has a recovery function.
Margin Recovery is the equivalent posture for the bottom line.
Margin Recovery is the operating discipline of reducing the labor and friction required to collect each dollar — at a faster pace than payer complexity erodes net collections.
The previous five sections sized the four conditions that make Margin Recovery the dominant strategic frame for 2026:
Move denial work from post-submission rework to pre-submission prediction. The highest-cost back-end labor (denials, appeals, write-offs) converts into low-cost front-end automation (validation, coding integrity, eligibility depth). A claim caught upstream costs cents; the same claim worked through appeals costs hundreds.
Eliminate the manual residue across high-volume electronic transactions: eligibility, claim status, remittance posting, prior authorization. Cycle speed and FTE-hours-per-million-collected move together when this lever works. Section 5 sized the residue at ~$21 billion annually industry-wide.
Specialists work the exceptions; automation clears the routine. The operational metric reported to the board shifts from simple headcount to charges-under-management per FTE — a ratio that holds even when claim volume grows.
Each vendor in the cycle is a workflow break, a license fee, and an integration tax. A unified system of record collapses three expense categories (license, integration, manual reconciliation) into one operational footprint. The hidden cost of a fragmented stack often equals or exceeds the visible cost of any single subscription.
This report's analysis is industry-wide. Margin Recovery is operation-specific. These five questions translate the framework into the diagnostic to bring into your 2026 review.
The 2% to 4% cost-to-collect benchmark applies to the top decile. Your numbers relative to that decile, segmented by category, and trended over 36 months, are the framing inputs for everything that follows. Operations that cannot answer this question precisely are not yet positioned to recover the margin they're losing. The answer is also the business case for automation, in dollars.
"Mostly electronic" hides the residue. The honest answer is rarely 90%+. The honest answer is the size of the opportunity. Walk one shift with a billing specialist and count the portal logins — that's the audit.
The trajectory is more diagnostic than the absolute number. A 9% denial rate that's been rising for 18 months is a worse problem than an 11% rate that's been falling for the same period. Segmentation by payer and CARC/RARC category is what turns the metric into a fixable workflow.
The Interoperability and Prior Authorization Final Rule entered its operational phase January 1, 2026 — faster PA decision timelines and mandatory denial specificity are live now. The first public PA performance metric reports were due March 31, 2026. The FHIR API compliance deadline lands January 1, 2027. Operations whose RCM stack cannot consume FHIR-based prior-auth APIs by then will operate at a structural disadvantage to those that can. The question is not whether to adapt; it is whether your current stack is on a path that can reach 2027 production-ready. If the answer is "we don't know," that is the next vendor conversation.
Vendor count is a proxy for friction. Vendor cost is a proxy for the floor under cost-to-collect. Both should move down. The integrated total is usually larger than the sum of subscription invoices because reconciliation labor and integration tax rarely live on any single vendor's P&L line.
The five questions are deliberately concrete. They are not "what is your strategy" — they are "what is your number". An RCM operator who can produce honest answers to all five has the working diagnostic for a 2026 Margin Recovery roadmap. An organization that cannot has identified its first priority before the planning meeting starts.
Healacle is the RCM orchestration layer for the revenue cycle — one platform that automates eligibility, claim status, claim submission, prior authorization, denial management, A/R follow-up, remittance posting, and executive reporting end-to-end, with best-of-breed AI plugged in per function. Purpose-built for revenue cycle management companies, whether they bill on their own chassis or work inside their clients' PMs. Our customers grow their charges under management without growing their teams — that is Margin Recovery in practice.
To see how Margin Recovery applies to your operation, visit healacle.com or contact our team to schedule a working session with your finance and revenue cycle leadership.
This report synthesizes published data from recognized industry authorities on healthcare financial performance, revenue cycle benchmarks, administrative transaction adoption, and labor market dynamics. No proprietary or non-public Healacle customer data appears in the analysis sections. All figures reflect the most recent publication dates available as of May 2026.
All citations reflect public data and analyses available as of May 2026. The conceptual framework — Margin Recovery as an operating discipline — is an original analytical lens introduced by Healacle and does not reflect any single cited source.